73340-44-0 Usage
General Description
3',5,6,7,8-Pentamethoxy-4',5'-(methylenedioxy)flavone is a natural chemical compound found in several plants, including Kaempferia parviflora. It is a flavonoid, a type of antioxidant compound known for its potential health benefits. The chemical structure of 3',5,6,7,8-Pentamethoxy-4',5'-(methylenedioxy)flavone consists of five methoxy groups attached to the flavone backbone, along with a methylenedioxy group located at positions 4' and 5'. This specific arrangement of functional groups gives the compound its unique properties and potential biological activities. Studies have shown that 3',5,6,7,8-Pentamethoxy-4',5'-(methylenedioxy)flavone may exhibit anti-inflammatory, antioxidant, and anti-cancer properties, making it of interest for potential use in medicine and functional foods. Further research is needed to fully understand its potential benefits and mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 73340-44-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,3,4 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73340-44:
(7*7)+(6*3)+(5*3)+(4*4)+(3*0)+(2*4)+(1*4)=110
110 % 10 = 0
So 73340-44-0 is a valid CAS Registry Number.
InChI:InChI=1/C21H20O9/c1-23-13-6-10(7-14-16(13)29-9-28-14)12-8-11(22)15-17(24-2)19(25-3)21(27-5)20(26-4)18(15)30-12/h6-8H,9H2,1-5H3
73340-44-0Relevant articles and documents
Synthesis of Polymethoxyflavonoids from Hesperidin and Naringin and their Antiproliferative Activity
Jin, Zhizhong,Liu, Kexiong,Su, Liang,Wang, Qiuan
, (2022/03/27)
[Figure not available: see fulltext.] A series of polymethoxyflavonoids were synthesized via cleavage of the glycosidic bond, dehydrogenation, selective methylation, bromination, nucleophilic aromatic substitution, O-prenylation, Claisen–Schmidt aldol condensation, cyclization, and oxidation from very abundant and inexpensive natural flavonoids hesperidin and naringin. The in vitro antiproliferative activity of the synthesized compounds was evaluated against a panel of four human cancer cell lines (Aspc-1, HCT-116, HepG-2, and SUN-5) by the CellTiter-Glo assay. The results showed that some of synthesized compounds exhibited moderate to high antiproliferative activity. Among them, (2E)-1-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(7-methoxy-1,3-benzodioxol-5-yl)prop-2-en-1-one was revealed to be the most active with IC50 values ranging from 10.35 to 13.89 μM against all four cancer cell lines, the IC50 value (10.35 μM) being below positive control cisplatin (12.36 μM) against HepG-2 cells.